BR112016012701A2 - peptídeos recentemente identificados para uso na indução de tolerância oral em mamíferos jovens - Google Patents
peptídeos recentemente identificados para uso na indução de tolerância oral em mamíferos jovensInfo
- Publication number
- BR112016012701A2 BR112016012701A2 BR112016012701A BR112016012701A BR112016012701A2 BR 112016012701 A2 BR112016012701 A2 BR 112016012701A2 BR 112016012701 A BR112016012701 A BR 112016012701A BR 112016012701 A BR112016012701 A BR 112016012701A BR 112016012701 A2 BR112016012701 A2 BR 112016012701A2
- Authority
- BR
- Brazil
- Prior art keywords
- milk
- peptides
- cow
- oral tolerance
- lactoglobulin
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 241000124008 Mammalia Species 0.000 title abstract 2
- 230000001939 inductive effect Effects 0.000 title abstract 2
- 230000020192 tolerance induction in gut-associated lymphoid tissue Effects 0.000 title abstract 2
- 102000008192 Lactoglobulins Human genes 0.000 abstract 3
- 108010060630 Lactoglobulins Proteins 0.000 abstract 3
- 235000020247 cow milk Nutrition 0.000 abstract 3
- 241000283707 Capra Species 0.000 abstract 1
- 208000009793 Milk Hypersensitivity Diseases 0.000 abstract 1
- 239000013566 allergen Substances 0.000 abstract 1
- 230000002009 allergenic effect Effects 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 235000020246 buffalo milk Nutrition 0.000 abstract 1
- 238000000586 desensitisation Methods 0.000 abstract 1
- 235000020251 goat milk Nutrition 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
Abstract
a presente invenção se refere a peptídeos identificados recentemente que são capazes de induzir tolerância ao leite de vaca, especialmente à ß-lactoglobulina. os peptídeos podem ser administra-dos a mamíferos, especialmente a bebês que estão em risco de alergia a proteínas do leite de vaca, para induzir tolerância oral ao leite de vaca; eles também podem ser administrados a crianças e adultos que são alérgicos ao leite de vaca para permitir que a "dessensibilização" a proteínas alergênicas do leite, especialmente a ß-lactoglobulina, ocorra. os peptídeos podem também ser usados para induzir tolerância ao leite de cabra e búfala, especialmente à ß-lactoglobulina. os peptídeos são capazes de modular a resposta imunológica de mamíferos aos alérgenos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2013/076643 WO2015090347A1 (en) | 2013-12-16 | 2013-12-16 | Newly identified peptides for use in the induction of oral tolerance in young mammals |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112016012701A2 true BR112016012701A2 (pt) | 2017-09-26 |
BR112016012701B1 BR112016012701B1 (pt) | 2022-11-16 |
Family
ID=49841652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016012701-3A BR112016012701B1 (pt) | 2013-12-16 | 2013-12-16 | Combinação de peptídeos para uso na indução de tolerância oral em mamíferos jovens, e composição |
Country Status (13)
Country | Link |
---|---|
US (1) | US10092633B2 (pt) |
EP (1) | EP3082842B1 (pt) |
CN (3) | CN117224652A (pt) |
AU (1) | AU2013407963B2 (pt) |
BR (1) | BR112016012701B1 (pt) |
ES (1) | ES2918577T3 (pt) |
MX (1) | MX2016007714A (pt) |
MY (1) | MY186968A (pt) |
PH (1) | PH12016501114B1 (pt) |
PT (1) | PT3082842T (pt) |
RU (1) | RU2668155C1 (pt) |
WO (1) | WO2015090347A1 (pt) |
ZA (1) | ZA201604931B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016148562A1 (en) * | 2015-03-18 | 2016-09-22 | N.V. Nutricia | Method for inducing oral tolerance via administration of beta-lactoglobulin derived peptide in combination with probiotic |
ES2807831T3 (es) | 2015-06-12 | 2021-02-24 | Nestle Sa | Combinacion de peptidos tolerogenos con TFG-â para inducir y mantener la tolerancia oral en mamiferos jovenes |
CN108314704B (zh) * | 2018-01-25 | 2020-03-17 | 海普诺凯营养品有限公司 | 一种羊乳清蛋白免疫调节肽、其制备方法及其应用 |
WO2019212330A1 (en) | 2018-04-30 | 2019-11-07 | N.V. Nutricia | Formula with a specific beta-lactoglobulin peptide |
WO2019212329A1 (en) | 2018-04-30 | 2019-11-07 | N.V. Nutricia | Formula with specific beta-lactoglobulin peptides |
AU2019473379A1 (en) | 2019-11-07 | 2022-04-14 | N.V. Nutricia | Extensive whey protein hydrolysate with tolerogenic peptides |
CN113311155B (zh) * | 2021-04-09 | 2022-11-29 | 深圳市计量质量检测研究院(国家高新技术计量站、国家数字电子产品质量监督检验中心) | 一种牛乳蛋白和水牛乳蛋白二联检测卡的制备方法及应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1200416A (en) | 1983-05-13 | 1986-02-11 | Societe Des Produits Nestle S.A. | Food process |
EP0321603A1 (fr) | 1987-12-23 | 1989-06-28 | Societe Des Produits Nestle S.A. | Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques |
GB9312369D0 (en) | 1993-06-16 | 1993-07-28 | Sandoz Nutrition Ltd | Organic compounds |
US5620348A (en) | 1995-05-12 | 1997-04-15 | Timex Corporation | Method of manufacturing electroluminescent lamps having surface designs and lamps produced thereby |
EP0880902A1 (fr) | 1997-05-27 | 1998-12-02 | Nestlé Produkte AG | Procédé de traitement d'une matiére première lactosérique |
MY129566A (en) | 1999-01-19 | 2007-04-30 | Nestle Sa | A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance |
JP3441411B2 (ja) * | 1999-10-12 | 2003-09-02 | 明治乳業株式会社 | コレステロール低減化ペプチド |
RU2192884C2 (ru) | 2000-11-09 | 2002-11-20 | Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН | Вакцина для стимуляции противоопухолевого иммунитета |
US20040007700A1 (en) | 2002-07-01 | 2004-01-15 | Hazel Danny G. | Non-snagging protective guide for fish tapes |
US20060286208A1 (en) * | 2005-06-01 | 2006-12-21 | Nagendra Rangavajla | Methods for producing protein partial hydrolysates and infant formulas containing the same |
WO2007004876A2 (en) * | 2005-06-30 | 2007-01-11 | Campina Nederland Holding B.V. | Peptides inhibiting angiotensin-converting enzyme |
ES2342625T5 (es) | 2006-02-10 | 2020-05-07 | Nestle Sa | Mezcla de oligosacáridos |
ES2524067T3 (es) | 2009-12-04 | 2014-12-03 | Mjn U.S. Holdings Llc | Formulación nutricional que comprende un hidrolizado que contiene péptidos de leche de vaca y/o péptidos derivados del mismo para la inducción de tolerancia |
WO2011150949A1 (en) * | 2010-06-04 | 2011-12-08 | N.V. Nutricia | Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
WO2012075570A1 (en) * | 2010-12-09 | 2012-06-14 | Mcgill University | Bioactive peptides and proteins containing bioactive peptides, their uses and processes for making the same |
US20130344042A1 (en) * | 2012-06-20 | 2013-12-26 | Gretchen Tanbonliong | Dietary management of celiac disease and food allergy |
-
2013
- 2013-12-16 CN CN202310924448.1A patent/CN117224652A/zh active Pending
- 2013-12-16 MY MYPI2016701453A patent/MY186968A/en unknown
- 2013-12-16 EP EP13811165.3A patent/EP3082842B1/en active Active
- 2013-12-16 BR BR112016012701-3A patent/BR112016012701B1/pt active IP Right Grant
- 2013-12-16 PT PT138111653T patent/PT3082842T/pt unknown
- 2013-12-16 CN CN201380081636.7A patent/CN105828830A/zh active Pending
- 2013-12-16 WO PCT/EP2013/076643 patent/WO2015090347A1/en active Application Filing
- 2013-12-16 ES ES13811165T patent/ES2918577T3/es active Active
- 2013-12-16 US US15/105,123 patent/US10092633B2/en active Active
- 2013-12-16 MX MX2016007714A patent/MX2016007714A/es active IP Right Grant
- 2013-12-16 AU AU2013407963A patent/AU2013407963B2/en active Active
- 2013-12-16 RU RU2016128923A patent/RU2668155C1/ru active
- 2013-12-16 CN CN202310924457.0A patent/CN117018181A/zh active Pending
-
2016
- 2016-06-10 PH PH12016501114A patent/PH12016501114B1/en unknown
- 2016-07-15 ZA ZA2016/04931A patent/ZA201604931B/en unknown
Also Published As
Publication number | Publication date |
---|---|
PH12016501114A1 (en) | 2016-07-11 |
EP3082842A1 (en) | 2016-10-26 |
BR112016012701B1 (pt) | 2022-11-16 |
CN117224652A (zh) | 2023-12-15 |
WO2015090347A1 (en) | 2015-06-25 |
ES2918577T3 (es) | 2022-07-19 |
MX2016007714A (es) | 2017-02-28 |
PT3082842T (pt) | 2022-06-17 |
PH12016501114B1 (en) | 2016-07-11 |
RU2016128923A (ru) | 2018-01-23 |
RU2668155C1 (ru) | 2018-09-26 |
US10092633B2 (en) | 2018-10-09 |
CN105828830A (zh) | 2016-08-03 |
US20160375114A1 (en) | 2016-12-29 |
ZA201604931B (en) | 2020-01-29 |
AU2013407963B2 (en) | 2019-10-10 |
MY186968A (en) | 2021-08-26 |
CN117018181A (zh) | 2023-11-10 |
EP3082842B1 (en) | 2022-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016012701A2 (pt) | peptídeos recentemente identificados para uso na indução de tolerância oral em mamíferos jovens | |
MX2020008455A (es) | Variantes de il-15 y usos de las mismas. | |
CO6640254A2 (es) | Método para preparar anticuerpos con propiedades mejoradas | |
CY1120740T1 (el) | Βελτιωμενα ευλογοϊικα εμβολια | |
MA42446A (fr) | Anticorps spécifiques de la protéine tau hyperphosphorylée et leurs procédés d'utilisation | |
BR112015024411A2 (pt) | desaza-purinonas macrocíclicas para o tratamento de infeções virais | |
BR112013024199A2 (pt) | métodos para melhorar a saúde óssea em bebês usando prebióticos | |
PE20151765A1 (es) | Formulas a base de hidrolizado de aminoacido y proteina con un sistema estable de emulsion | |
BR112019014397A2 (pt) | Composições de neisseria meningitidis e métodos das mesmas | |
CL2016000538A1 (es) | Compuesto que comprende la proteína globo h y klh, composiciones de una vacuna de hidratos de carbono para la inducción de respuestas inmunes y usos de los mismos | |
MA47113A (fr) | Protéines de liaison à l'antigène anti- neuropiline et leurs méthodés d'utilisation | |
CY1123403T1 (el) | Τροποποιημενα κυτταρα ξενιστες και χρησεις αυτων | |
PH12019550208A1 (en) | Hmos blends for use in infants or young children for health purposes | |
EP4272750A3 (en) | Protein antigens that provide protection against pneumococcal colonization and/or disease | |
BR112016030774A2 (pt) | anticorpo ou fragmento de ligação a antígeno do mesmo, uso de um anticorpo, métodos para redução da quantidade de protofibrilas de ?? em um indivíduo, para tratamento e/ou para profilaxia de uma doença, para medição da quantidade de protofibrilas de ?? e/ou de proteína ?? agregada em uma pessoa, e para diagnóstico de uma doença, e, composição farmacêutica | |
PE20142082A1 (es) | Composiciones nutricionales de caseina - suero de leche parcialmente hidrolizadas para reducir la aparicion de alergias | |
AR106624A1 (es) | Composiciones nutricionales que contienen butirato dietario y usos de las mismas | |
BR112018016912A2 (pt) | novo antígeno para uso na vacina contra malária | |
MA46111A (fr) | Bactéries génétiquement modifiées sécrétant des protéines thérapeutiques et procédés d'utilisation de celles-ci | |
BR112017022755A2 (pt) | formulações de glucopiranosil lipídeo a e alérgeno a amendoim para administração sublingual | |
BR112017013574A2 (pt) | conjugados de aminoácido e peptídeo e usos dos mesmos | |
BR112017002173A2 (pt) | anticorpos semelhantes à angiopoietina e métodos de uso | |
PH12016500772A1 (en) | Synthetic milk compositions comprising n-6 eicosatrienoic acid and polar lipids for infants younger and older than three months for healthy establishment of cognitive function | |
BR112017020606A2 (pt) | ?composições e métodos de uso de peptídeos de interleucina-10 e anticorpos anti-interleucina? | |
CO7310519A2 (es) | Enriquecedor para un sucedáneo de la leche materna |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH) |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/12/2013, OBSERVADAS AS CONDICOES LEGAIS |